Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Lara Iglesias"'
Autor:
Jordi Rubió-Casadevall, Beatriz Cirauqui Cirauqui, Javier Martinez Trufero, Maria Plana Serrahima, Almudena García Castaño, Alberto Carral Maseda, Lara Iglesias Docampo, Pedro Pérez Segura, Isaac Ceballos Lenza, Vanesa Gutiérrez Calderón, José Fuster Salvà, Carolina Pena Álvarez, Irene Hernandez, Edel del Barco Morillo, Manuel Chaves Conde, Joaquina Martínez Galán, Marisa Durán Sánchez, Vanesa Quiroga, Eugenia Ortega, Ricard Mesia
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesThe aim of this study was to confirm the efficacy of the ERBITAX scheme (paclitaxel 80 mg/m2 weekly and cetuximab 400 mg/m2 loading dose, and then 250 mg/m2 weekly) as first-line treatment for patients with recurrent/metastatic squamous cel
Externí odkaz:
https://doaj.org/article/2c2ce3b877f44930902325a31aadefe0
Autor:
Analia Rodríguez-Garzotto, Lara Iglesias-Docampo, C. Vanesa Díaz-García, Isabel Ruppen, Pilar Ximénez-Embún, Carlos Gómez, J. Luis Rodríguez-Peralto, Javier Ortiz de Frutos, Jose A. Lopez-Martin, Cristina Grávalos, Hernán Cortés-Funes, M. Teresa Agulló-Ortuño
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Hand-foot syndrome (HFS) is a common adverse reaction associated with capecitabine chemotherapy that significantly affects the quality of life of patients. This study evaluates the safety and effectiveness of a topical heparin (TH) treatm
Externí odkaz:
https://doaj.org/article/db84b09780b040ebac8582665d7c2c82
Autor:
Hernández, Juan Jesús Cruz, Arrula, Virginia Arrazubi, Álvarez, Yolanda Escobar, Castaño, Almudena García, de Castro, Juan José Grau, Docampo, Lara Iglesias, Sorrosal, Julio Lambea, Segura, Pedro Pérez, Domínguez, Antonio Rueda, Campos-Lucas, Francisco J., Rodríguez, Irene Santamaría, Bessa, Maria, Gratal, Paula, Caballero-Martínez, Fernando, Martín, Diana Monge, Antón-Rodríguez, Cristina, López, Rafael
Publikováno v:
Clinical & Translational Oncology; May2024, Vol. 26 Issue 5, p1089-1097, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ramalingam, Suresh S, Jänne, Pasi A, Mok, Tony, O'Byrne, Kenneth, Boyer, Michael J, Von Pawel, Joachim, Pluzanski, Adam, Shtivelband, Mikhail, Docampo, Lara Iglesias, Bennouna, Jaafar, Zhang, Hui, Liang, Jane Q, Doherty, Jim P, Taylor, Ian, Mather, Cecile B, Goldberg, Zelanna, O'Connell, Joseph, Paz-Ares, Luis
Publikováno v:
In The Lancet Oncology November 2014 15(12):1369-1378
Autor:
Jon Cacicedo, Ricard Mesia, José Luis Aguilar-Ponce, Thiago Bueno Oliveira, Tannia Soria, Neck Cancer, Agustin Falco, Antonio Rueda-Domínguez, Miren Taberna, Taysser Sowley, Marcos David Pereira, Héctor Galindo, Aylen Vanessa Ospina, Miguel Ángel Ticona, Lara Iglesias
Publikováno v:
Cancer Management and Research
Cisplatin is the standard of treatment for squamous cell carcinoma of the head and neck (SCCHN) that has demonstrated efficacy, either in locally advanced disease when combined with radiotherapy at high doses, or in metastatic/recurrent disease when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04b3f59c20cb009dcada71e539634ef7
https://doi.org/10.2147/cmar.s322411
https://doi.org/10.2147/cmar.s322411
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-18 (2021)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Nasopharyngeal carcinoma (NPC) represents a molecularly paradigmatic tumor given the complex diversity of environmental as well as host dependent factors that are closely implicated in tissue transformation and carcinogenesis. Epstein Barr Virus (EBV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1956c19adf861d89bbf3cdfe2f3d3756
https://doaj.org/article/69d30d5cc6f344f0862b54b6d050f096
https://doaj.org/article/69d30d5cc6f344f0862b54b6d050f096
Autor:
Ezra E. Cohen, Jérôme Fayette, Amaury Daste, Caroline Even, Christophe Le Tourneau, Irene Brana, Esma Saada, Elisa Fontana, Lara Iglesias, Shumei Kato, Rocio Garcia-Carbonero, Josep Tabernero, Guillem Argilés, Marina Magin, Yu-Ming Shen, Renée de Leeuw, Mohamed Bekradda, Eduardo Pennella, Ernesto Wasserman, Viktoriya Stalbovskaya, Jeroen Lammerts van Bueren, Lokesh Jain, Andrew Joe, Antoine Hollebecque
Publikováno v:
Cancer Research. 83:CT012-CT012
EGFR is a known driver of cancer growth, and leucine-rich, repeat-containing, G-protein coupled receptor 5 (LGR5) is a transmembrane receptor expressed on cancer stem cells. Petosemtamab is a human, common light chain, IgG1 bispecific antibody with A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60fed28e03ff36e5fa9cae64d837f3c3
https://doi.org/10.1158/1538-7445.am2023-ct012
https://doi.org/10.1158/1538-7445.am2023-ct012
Autor:
Virginia Pardo-Marqués, M. Teresa Agulló-Ortuño, Laura Ojeda, Lara Iglesias, Irene Ferrer, Óscar Gómez-Martín, Luis Paz-Ares, Santiago Ponce, Inmaculada García-Ruiz
Publikováno v:
Clinical Lung Cancer. 21:75-85
Background Immunotherapy is a promising cancer treatment, but surrogate biomarkers of clinical efficacy have not been fully validated. The aim of this work was to evaluate several biomarkers as predictors of response to nivolumab monotherapy in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddd7878956051f8808f2c23b19242bf0
https://doi.org/10.1016/j.cllc.2019.08.006
https://doi.org/10.1016/j.cllc.2019.08.006